Bright Minds Biosciences: Newest Psychedelics Company To Join The Nasdaq
Wall Street is welcoming yet another company working with psychedelic molecules for mental health and neurological treatments.
Bright Minds Biosciences (CSE: DRUG) received approval on Wednesday to effectively list its stock on the Nasdaq starting next Monday, November 8 under the symbol “DRUG.”